Verastem (VSTM) Profit After Tax (2011 - 2026)
Verastem's (VSTM) quarterly Profit After Tax came in at -$36.6 million in Q1 2026, up 29.77% year-on-year from -$28.2 million in Q1 2025, and down 20.48% quarter-over-quarter from -$30.4 million in Q4 2025.
Verastem (VSTM) Profit After Tax (2011 - 2026) Analysis & Trends
Verastem's Profit After Tax history runs 16 years deep, the most recent figure standing at -$36.6 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 29.77% year-over-year to -$36.6 million in Q1 2026; TTM through Mar 2026 was -$191.4 million, a 28.57% decrease from a year earlier, with the FY2025 full-year figure at -$209.5 million, down 60.33% from the prior year.
- Profit After Tax declined to -$36.6 million in Q1 2026 per VSTM's latest filing, from -$30.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$8.3 million in Q2 2024 and bottomed at -$98.5 million in Q3 2025.
- The 5-year median for Profit After Tax is -$24.3 million (2023), against an average of -$31.5 million.
- Across the five-year window, Profit After Tax surged 66.0% in 2024 and sank 311.06% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$16.8 million in 2022, then plunged by 62.5% to -$27.4 million in 2023, then plunged by 135.86% to -$64.6 million in 2024, then surged by 52.95% to -$30.4 million in 2025, then declined by 20.48% to -$36.6 million in 2026.
- Per Business Quant, the three latest VSTM Profit After Tax figures stand at -$36.6 million (Q1 2026), -$30.4 million (Q4 2025), and -$98.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -36.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.59 Mn |
| Dec 31, 2025 | -30.37 Mn |
| Sep 30, 2025 | -98.52 Mn |
| Jun 30, 2025 | -25.93 Mn |
| Mar 31, 2025 | -52.10 Mn |
| Dec 31, 2024 | -64.55 Mn |
| Sep 30, 2024 | -23.97 Mn |
| Jun 30, 2024 | -8.26 Mn |
| Mar 31, 2024 | -33.86 Mn |
| Dec 31, 2023 | -27.37 Mn |
| Sep 30, 2023 | -19.96 Mn |
| Jun 30, 2023 | -24.28 Mn |
| Mar 31, 2023 | -15.71 Mn |
| Dec 31, 2022 | -16.84 Mn |
| Sep 30, 2022 | -18.00 Mn |
| Jun 30, 2022 | -21.95 Mn |
| Mar 31, 2022 | -16.96 Mn |
| Dec 31, 2021 | -16.50 Mn |
| Sep 30, 2021 | -22.79 Mn |
| Jun 30, 2021 | -16.90 Mn |